发明名称 |
Use of high dose pridopidine for treating Huntington's disease |
摘要 |
This invention provides a method of treating a human patient afflicted with Huntington's disease, comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine or a pharmaceutically acceptable salt thereof such that greater than 135 mg of pridopidine is administered to the patient per day. This invention further provides a method of treating a human patient afflicted with Huntington's disease, comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine hydrochloride such that greater than 90 mg of pridopidine is administered to the patient per day. |
申请公布号 |
AU2014281414(A1) |
申请公布日期 |
2016.01.21 |
申请号 |
AU20140281414 |
申请日期 |
2014.06.19 |
申请人 |
TEVA PHARMACEUTICALS INTERNATIONAL GMBH |
发明人 |
BASSAN, MERAV;EYAL, ELI;HAGAI, ESTHER LUKASIEWICZ;SVEINSDOTTER TEIGE WICKENBERG, ANNA KRISTINA |
分类号 |
A61K31/445 |
主分类号 |
A61K31/445 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|